CREYON Trademark

Trademark Overview


On Friday, July 23, 2021, a trademark application was filed for CREYON with the United States Patent and Trademark Office. The USPTO has given the CREYON trademark a serial number of 90846005. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Friday, September 6, 2024. This trademark is owned by Creyon Bio, Inc.. The CREYON trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and scientific research in the field of Oligonucleotide-Based Medicines; Oligonucleotide-Based drug development services; engineering and chemical synthesis of oligonucleotide-based medicines and their building blocks and delivery technologies; engineering and chemical synthesis of oligonucleotide therapeutics and their building blocks and delivery technologies; experimental assessment of pharmacological and chemical properties of oligonucleotide-base medicines in the nature of pharmaceutical research and development; designing clinical trial studies for others; providing medical and scientific research information in the fields of Oligonucleotide-Based Medicine clinical trials; platform as a service (PaaS) featuring computer software platforms for data creation and collection using artificial intelligence for precision medicine, namely, to decode diseases, develop targeted Oligonucleotide-Based Medicine treatments and therapies, and to select patients that will respond to Olig...
creyon

General Information


Serial Number90846005
Word MarkCREYON
Filing DateFriday, July 23, 2021
Status732 - THIRD EXTENSION - GRANTED
Status DateFriday, September 6, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 24, 2023

Trademark Statements


Goods and ServicesMedical and scientific research in the field of Oligonucleotide-Based Medicines; Oligonucleotide-Based drug development services; engineering and chemical synthesis of oligonucleotide-based medicines and their building blocks and delivery technologies; engineering and chemical synthesis of oligonucleotide therapeutics and their building blocks and delivery technologies; experimental assessment of pharmacological and chemical properties of oligonucleotide-base medicines in the nature of pharmaceutical research and development; designing clinical trial studies for others; providing medical and scientific research information in the fields of Oligonucleotide-Based Medicine clinical trials; platform as a service (PaaS) featuring computer software platforms for data creation and collection using artificial intelligence for precision medicine, namely, to decode diseases, develop targeted Oligonucleotide-Based Medicine treatments and therapies, and to select patients that will respond to Oligonucleotide-Based Medicine treatments and therapies; platform as a service (PaaS) featuring computer software platforms for data creation and collection using artificial intelligence for big data analytics, predictive data analytics, and predictive modeling, and multivariate analytics; platform as a service (PaaS) featuring data creation and collection tools, computer platforms and software using artificial intelligence for bioinformatics, simulations in clinical trials or studies, the designing of clinical trials or studies, and the de-risking of clinical trial or study designs and clinical trials simulations

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, September 23, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCreyon Bio, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Party NameCreyon Bio, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events


Event DateEvent Description
Thursday, May 12, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, July 27, 2021NEW APPLICATION ENTERED
Thursday, September 23, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, April 18, 2022ASSIGNED TO EXAMINER
Thursday, May 12, 2022NON-FINAL ACTION WRITTEN
Thursday, May 12, 2022NON-FINAL ACTION E-MAILED
Friday, November 11, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, November 11, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, November 11, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, December 19, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 4, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 24, 2023PUBLISHED FOR OPPOSITION
Tuesday, January 24, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Friday, September 15, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, March 21, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, September 15, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, September 20, 2023SOU TEAS EXTENSION RECEIVED
Friday, September 15, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, September 20, 2023SOU EXTENSION 1 FILED
Wednesday, September 20, 2023SOU EXTENSION 1 GRANTED
Monday, March 11, 2024SOU EXTENSION 2 GRANTED
Monday, March 11, 2024SOU TEAS EXTENSION RECEIVED
Monday, March 11, 2024SOU EXTENSION 2 FILED
Friday, September 6, 2024SOU TEAS EXTENSION RECEIVED
Friday, September 6, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 6, 2024SOU EXTENSION 3 GRANTED
Friday, September 6, 2024SOU EXTENSION 3 FILED
Tuesday, March 12, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 22, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED